Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down 0.08% Nasdaq Down 0.11%
Streaming
Ticker Tape: On

Celgene Corporation (CELG)

-NasdaqGS

123.64 Up 0.20(0.16%) May 23, 4:00PM EDT|After Hours : 123.64 0.00 (0.00%) May 23, 7:06PM EDT

Add to Portfolio
Prev Close:123.44
Open:121.95
Bid:114.00 x 100
Ask:123.95 x 300
1y Target Est:134.22
Beta:0.92
Next Earnings Date:25-Jul-13CELG Earnings announcement
Day's Range:120.55 - 124.97
52wk Range:58.53 - 131.82
Volume:2,370,746
Avg Vol (3m):3,213,210
Market Cap:51.57B
P/E (ttm):37.61
EPS (ttm):3.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 0.16%51.57B
RHHBYN.MXUp 0.14%2.66T
SHP.LDown 0.97%11.77B
SUNPHARMA.NSDown 3.08%1.01T
GILD.MXDown 1.48%1.04T

Key Statistics

Forward P/E (1 yr):17.92
P/S (ttm):9.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :5.75
Quarterly EPS Est (Jun-13) :1.43
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.96

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and immune-inflammatory related diseases in the United States, Europe, and other countries. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback